Phase 1 Experience With an Anti-Glycotope Monoclonal Antibody, RAV12, in Recurrent Adenocarcinoma
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-09-2263
Full Text
Open PDFAbstract
Available in full text
Date
February 23, 2010
Authors
Publisher
American Association for Cancer Research (AACR)